Everolimus is currently used as an immunosuppressant to prevent rejection of organ transplants. It is a derivative of Rapamycin, and works similarly to Rapamycin as an mTOR inhibitor. Reference standards of Everolimus API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => 2-((tert-Butyldimethylsilyl)oxy)ethyl 2,2,2-trichloroacetimidate [catalogue_number] => PA 05 73530 [category_ids] => ,84, [chemical_name] => [weight] => 320.72 [form] => C10H20Cl3NO2Si [cas] => NA [pslug] => 2-tert-butyldimethylsilyl-oxy-ethyl-2-2-2-trichloroacetimidate-pa0573530 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 05 73530
CAS :
Molecular Formula : C10H20Cl3NO2Si
Molecular Weight : 320.72
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....